What are the recommended birth control options for obese women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Birth Control Options for Obese Women

All contraceptive methods can be safely used by obese women (BMI ≥30 kg/m²), with intrauterine devices (IUDs) and implants being the most effective options regardless of body weight. 1

First-Line Recommendations for Obese Women

  • Intrauterine Devices (IUDs): Both copper and levonorgestrel-releasing IUDs are classified as Category 1 (no restrictions) for obese women, with no reduction in effectiveness related to body weight 1
  • Contraceptive Implants: The etonogestrel implant is classified as Category 1 for obese women with no evidence of reduced effectiveness 1
  • Injectable Contraceptives: Depot medroxyprogesterone acetate (DMPA) is Category 1 for obese women with maintained effectiveness 1, 2

Second-Line Options

  • Progestin-Only Pills (POPs): Classified as Category 1 for obese women with no restrictions on use 1, 3
  • Combined Hormonal Contraceptives (CHCs): Classified as Category 2 (benefits generally outweigh risks) for obese women without additional cardiovascular risk factors 1, 3

Special Considerations for Obese Women

Combined Hormonal Contraceptives (Pills, Patch, Ring)

  • Obese women using CHCs have an increased risk of venous thromboembolism (VTE) compared to non-users, though absolute risk remains small 3
  • When obesity is combined with other cardiovascular risk factors (smoking, hypertension, etc.), CHCs become Category 3/4 (risks may outweigh benefits) 1, 3
  • Blood pressure measurement is required before CHC initiation 1

Transdermal Patch

  • Evidence suggests decreased effectiveness in women weighing >90 kg 3, 2
  • Consider alternative methods for women above this weight threshold 2

Emergency Contraception

  • Levonorgestrel emergency contraception may have reduced effectiveness in obese women 1, 4
  • Ulipristal acetate or copper IUD are preferred emergency contraception options for obese women 1

Post-Bariatric Surgery

  • For restrictive procedures (gastric banding, sleeve gastrectomy): all contraceptive methods remain Category 1 1, 3
  • For malabsorptive procedures (gastric bypass): oral contraceptives are Category 3 (risks usually outweigh benefits) due to potential decreased absorption 1, 3
  • IUDs and implants are preferred after malabsorptive bariatric procedures 3

Pre-Initiation Requirements

  • Weight/BMI measurement: Not required for determining medical eligibility for any contraceptive method, as all methods can be used by obese women 1
  • Blood pressure: Required only for combined hormonal contraceptives 1
  • Bimanual examination and cervical inspection: Required only for IUD insertion 1
  • STD screening: Not routinely required before contraceptive initiation unless indicated by risk factors 1

Common Pitfalls to Avoid

  • Assuming decreased effectiveness of all hormonal methods in obese women - most methods maintain full effectiveness regardless of weight 1, 2
  • Failing to consider the combined effect of obesity with other cardiovascular risk factors when prescribing CHCs 3
  • Overlooking the potential reduced effectiveness of the transdermal patch in women >90 kg 3, 2
  • Not considering the impact of bariatric surgery type on contraceptive absorption 3

Algorithm for Contraceptive Selection in Obese Women

  1. First assess for additional cardiovascular risk factors (smoking, hypertension, diabetes, dyslipidemia)
  2. If no additional risk factors: All methods are appropriate, with LARCs (IUDs, implants) being most effective
  3. If additional risk factors exist: Avoid CHCs; recommend IUDs, implants, DMPA, or POPs
  4. For women post-bariatric surgery: Choose based on procedure type (avoid oral methods after malabsorptive procedures)
  5. For women >90 kg: Consider avoiding the transdermal patch due to potential reduced effectiveness

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hormonal contraceptives for contraception in overweight or obese women.

The Cochrane database of systematic reviews, 2016

Guideline

Prescribing Oral Contraceptives in Morbidly Obese Females

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hormonal contraception and obesity.

Fertility and sterility, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.